Para poder acceder a la web de la GT debes tener el código de registro de la 8a edición de la Guía. No son válidos los códigos de ediciones anteriores. Si no has registrado tu código, debes hacerlo aquí.

Registrarse

¿Has olvidado la contraseña?

Para cualquier consulta o incidencia, puedes contactarnos a través del correo guiaterapeutica@semfyc.es

Problemas de la cara-nariz-boca-garganta-oídos

Acúfenos

  • Agency for Healthcare Research and Quality. Evaluation and treatment of tinnitus: Comparative effectiveness; 2013. https://effectivehealthcare.ahrq.gov/topics/tinnitus/research
  • Biesinger E, Del Bo L, De Ridder D, and cols. Algorithm for the diagnostic and therapeutic management of tinnitus. TRI Tinnitus Clinic Network. 2010.
  • Folmer R, Hal M, Yongbing S. Tinnitus: Questions to reveal the cause, answers to provide relief. J Fam Pract 2004.
  • Hoare DJ, Edmondson-Jones M, Sereda M, Akeroyd MA, Hall D. Amplification with hearing aids for patients with tinnitus and co-existing hearing loss. Cochrane Database Syst Rev. 2014;1:CD010151.
  • Hoare DJ, Kowalkowski VL, Kang S, Hall DA. Systematic review and meta-analyses of randomized controlled trials examining tinnitus management. Laryngoscope. 2011;121(7):1555.
  • Martínez-Devesa P, Perera R, Theodoulou M, Waddell A. Terapia cognitivo conductual para el tinnitus. Cochrane Database of Systematic Reviews 2010 Issue 9. Art. No.: CD005233.
  • Parazzini M, Del Bo L, Jastreboff M, Tognola G, Ravazzani P. Open ear hearing aids in tinnitus therapy: An efficacy comparison with sound generators. Int J Audiol. 2011 Aug;50(8):548-53. Epub 2011 May 19.
  • Tinnitus: assessment and management. NICE guideline Published: 11 March 2020. Disponible en: http://www.nice.org.uk/guidance/ng155
  • Tunkel D, Bauer C. Clinical Practice Guideline: Tinnitus. Otolaryngology–Head and Neck Surgery 2014, Vol. 151(2S) S1–S40. Disponible en: https://journals.sagepub.com/doi/pdf/10.1177/0194599814545325
  • Waddel A. Acúfenos. En: Centro Cochane Iberoamericano. Evidencia clínica concisa. Bogotá: Legis; 2006-07:464-6.

Afta bucal

  • Edgar NR, Saleh D, Miller RA. Recurrent Aphthous Stomatitis: A Review. J Clin Aesthet Dermatol 2017; 10:26.
  • Liu C, Zhou Z, Liu G, et al. Efficacy and safety of dexamethasone ointment on recurrent aphthous ulceration. Am J Med 2012; 125:292.
  • Prodigy Guidance 2007 [acceso Jul 2008]. Disponible en: http://www. prodigy.nhs.uk/
  • Purriños L, Fernández-Obanza E. Aftas orales. AMF 2008;4(1):38-40.
  • Scully C, Porter S. Enfermedad de la mucosa oral: estomatitis aftosa recurrente. Br J Oral Maxillofac Surg 2008; 46: 198.
  • Tarakji B, Gazal G, Al-Maweri SA, et al. Guideline for the diagnosis and treatment of recurrent aphthous stomatitis for dental practitioners. J Int Oral Health 2015; 7:74.

Candidiasis oral

  • Akpan A, Morgan R. Oral candidiasis. Postgraduate Medical Journal. 2002;78(922):455-9.
  • Clarkson JE, Worthington HV, Eden OB. Intervenciones para la prevención de la candidiasis oral en pacientes con cáncer que reciben tratamiento (Revisión Cochrane traducida). En: Biblioteca Cochrane Plus, 2008, número 2. Oxford: Update Software Ltd. Disponible en: http://www.update-software.com
  • DynaMed Plus [Internet]. Ipswich (MA): EBSCO Information Services. 1995 - . Record No. 114902, Oral candidiasis; [updated 2016 Apr 14, consultado 7 sept 2018]; http://www.dynamed.com/login.aspx?direct=true&site=DynaMed&id=114902
  • Monedero M, García C, Rabanaque G, Marín P, Batalla M. Protocolo de tratamiento empírico de las infecciones en el adulto. FMC 2007;14:30-6.
  • Panel on Opportunistic Infections in HIV-Infected Adults and Adolescents. Guidelines for the prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: Recommendations from the Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. [Consulta realizada el 29 de septiembre de 2019]. Disponible en: http://aidsinfo.nih.gov/contentfiles/lvguidelines/adult_oi.pdf
  • Su CW, Gaskie S, Jamieson B, Triezenberg D. What is the best treatment for oral thrush in healthy infants? Journal of Family Practice July. 2008;vol.57,No.7:484-5.

Disfonía

  • Amor JC, Costa C. Disfonía. [Internet.] Guías clínicas Fisterra. 2015. Disponible en: www.fisterra.com/guías-clínicas/disfonia/
  • Bruch J, Kamani D. Hoarseness in adults. [Internet.] UpToDate 2016. Disponible en: http://www.uptodate.com
  • Chang JI, Bevans SE, Schwartz SR. Otolaryngology clinic of North America: evidence based practice: management of hoarseness/dysphonia. Otolaryngol Clin North Am. 2012;45(5):1109-26.
  • Romero E, Martín A, De Mier M. Disfonía. FMC 2008;15(2):62-9.
  • Ruotsalainen JH, Sellman J, Lehto L, Jauhiainen M, Verbeek JH. Intervenciones para el tratamiento de la disfonía funcional en adultos (Revisión Cochrane traducida). En: Biblioteca Cochrane Plus, 2008, número 4. Oxford: Update Software Ltd. Disponible en: http://www.update-software.com

Disfunción de la articulación temporomandibular

  • Buescher JJ. Temporomandibular joint disorders. American Family Physician. 2007;76 (10):1477-82.
  • Gauer RL, Semidey MJ. Diagnosis and treatment of temporomandibular disorders. Am Fam Physician. 2015 Mar 15;91(6):378-86. PMID: 25822556.

  • Koh H, Robinson P. Occlusal adjustment for treating and preventing temporomandibular joint disorders. Cochrane Database of Systematic Reviews 2003, Issue 1. Art. No.: CD003812.
  • Manfredini D, Lobbezoo F. A systematic review of the effectiveness of exercise, manual therapy, electrotherapy, relaxation training, and biofeedback in the management of temporomandibular disorder. Physical Therapy. 2010;86(7):955-73.
  • Medlicott MS, Harris AR. Una revisión sistemática de la efectividad del ejercicio, terapia manual, electroterapia, ejercicios de relajación y biofeedback en el tratamiento del trastorno temporomandibular. Hay Phys. 2006 Jul;86(7):955-73.
  • Revisión de las directrices para el tratamiento de los trastornos temporomandibulares conjunto aprobado por el "Consejo de la AADR" 3 marzo de 2010. [Artículo Diario, Guía de Práctica]. Rev Med Dent Belge (1984). 2010 Oct-Dec;65(4):163-4.

Dolor dental y periodontal

  • Agnihotry A, Thompson W, Fedorowicz Z, van Zuuren EJ and Sprakel J. Antibiotic use for irreversible pulpitis. Cochrane Database Syst Rev.; 2016 Feb. Prim Dent J. 2014 Feb;3(1):52-7.
  • Bascones A, Aguirre J, Bermejo A. Documento de consenso sobre el tratamiento antimicrobiano de las infecciones bacterianas odontogénicas. Av Odontoestomatol. 2005;21:311-9.
  • Calsina E, Vichino S. Enfermedad periodontal. Formación Médica Continuada. 2001;2:68-76.
  • Cope A al. Systemic antibiotics for symptomatic apical periodontitis and acute apical abscess in adults. Cochrane Database Syst Rev.; 2014 Jun 26; 6.
  • Daly CG. Antibiotic prophylaxis for dental procedures. Aust Prescr 2017;40:184-8.
  • Dental abscess – Management Institute for Clinical Systems Improvement. 2008 Ene. Natinal Guideline Clearinghouse. [Actualizada Ene 2008; acceso 9 Jul 2008]. Disponible en: http://www.prodigy.nhs.uk/dental_abscess
  • Douglas PR. Management of severe acute dental infections. BMJ 2015; 350.
  • Monedero M, García C, Rabanaque G, Marín P, Batalla M. Tratamiento empírico de las infecciones en el adulto. FMC 2008;Protocolo 4/2008 30-5.
  • Prevention and treatment of periodontal diseases in Primary Care.2014. Dental Clinical Guidance. Scottish Dental Clinical Effectiveness Programme. Disponible en: http://www.sdcep.org.uk
  • Segura-Egea JJ, Gould K, Şen BH, Jonasson P, Cotti E, Mazzoni A, et al. European Society of Endodontology position statement: the use of antibiotics in endodontics. Int Endod J 2018;51:20-5.
  • Timmerman A, Parashos P. Management of dental pain in primary care. Aust Prescr. 2020;43(2):39-44. doi:10.18773/austprescr.2020.010.

Epistaxis

  • Bequignon E, Vérillaud B, Robard L, et al; SFORL work-group. Guidelines of the French Society of Otorhinolaryngology (Société Française d'Oto-Rhino-Laryngologie [SFORL]). First-line treatment of epistaxis in adults. Eur Ann Otorhinolaryngol Head Neck Dis. 2017 May;134(3):185-189
  • Biswas D, Mal RK. Are systemic prophylactic antibiotics indicated with anterior nasal packing for spontaneous epistaxis? Acta Otolaryngol. 2009 Feb;129(2):179-81.
  • García E, González X. Técnica para la colocación de un taponamiento nasal anterior. AMF 2006:2(1):29-32.
  • García S, Millán J. Epistaxis. 2016. Disponible en: http://www.fisterra.com/fisterrae/
  • Pennekamp A, Tschirky P, Grossenbacher R. Importancia de Staphylococcus aureus en las operaciones de la nariz. Riesgo de síndrome de shock tóxico. ENT. 1995;43(11):664.
  • Pepper C, Lo S, Toma AJ. Prospective study of the risk of not using prophylactic antibiotics in nasal packing for epistaxis. Laryngol Otol. 2012 Mar;126(3):257-9.
  • Tunkel D, Anne S, MD Clinical Practice Guideline: Nosebleed (Epistaxis) Otolaryngology–Head and Neck Surgery 2020, Vol. 162(1S) S1–S38. Disponible en: https://journals.sagepub.com/doi/pdf/10.1177/0194599819890327

Faringitis

  • Alberta Health Services Bugs & Drugs. Pharyngitis. Consulta realizada el 29 Sep 2018. Disponible en : http://bugsanddrugs.org/Home/Index/bdpage9C234740DFE046A8AF4D2F001B0A4E79
  • Bercedo A, Cortés O, García C, Montón JL. Normas de Calidad para el diagnóstico y tratamiento de la Faringo-amigdalitis aguda en Pediatría de Atención Primaria. Protocolos del GVR (publicación P-GVR-10) [Actualizado 9 sep 2011. Consulta realizada el 29 Sep 2018]. Disponible en: http://www.respirar.org/images/pdf/grupovias/faringoamigdalitis2011.pdf
  • Del Mar CB, Glasziou PP, Spinks AB. Antibióticos para la faringitis (Revisión Cochrane traducida). En: Biblioteca Cochrane Plus, 2008, número 2. Oxford: Update Software Ltd. Disponible en: http://www.update-software.com
  • Finnish Medical Society Duodecim. Tonsillitis and pharyngitis in children. En: EBM Guidelines. Evidence-Based Medicine [CD-ROM] [Consulta realizada el 25 Jun 2008]. Helsinki, Finland: Duodecim Medical Publications Ltd; 2005 [revisión por NGC en: http://guidelines.gov/content.aspx?id=11049]
  • Gerber MA, Baltimore RS, Eaton CB, et al. Prevention of rheumatic fever and diagnosis and treatment of acute Streptococcal pharyngitis: a scientific statement from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young, the Interdisciplinary Council on Functional Genomics and Translational Biology, and the Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics. Circulation 2009; 119:1541.
  • Llor C, Moragas A, Hernández S. Infecciones del tracto respiratorio. AMF. 2011:7(3):124-135.
  • Michigan Quality Improvement Consortium. Acute pharyngitis in children 2-18 years old. Southfield (MI): Michigan Quality Improvement Consortium; 2011 Jan.
  • NICE guideline [NG84]. Sore throat (acute): antimicrobial prescribing. Jan 2018, Disponible en : www.nice.org.uk/guidance/ng84
  • Picazo J, Betriu C, Rodríguez-Avial I, Gómez M, Culebras E. Vigilancia de resistencias a los antimicrobianos: estudio VIRA 2004. Microbiol Clin. 2004;22(9);517-25.
  • Piñeiro R, Hijano F, Älvez F, Fernández A, Silva JC, Pérez C, et al. Documento de consenso sobre el diagnóstico y tratamiento de la faringoamigdalitis aguda. An Pediatr (Barc). 2011;75(5):342.e1-342.e13.
  • Spinks A, Glasziou PP, Del Mar CB. Antibiotics for sore throat. Cochrane Database of Systematic Reviews 2013, Issue 11. Art. No.: CD000023. Disponible en : https://www.cochranelibrary.com/es/cdsr/doi/10.1002/14651858.CD000023.pub4/full/es?highlightAbstract=antibioticos&highlightAbstract=antibiotic&highlightAbstract=antibiotico&highlightAbstract=o
  • Stelter K. [Tonsillitis and sore throat in childhood]. Laryngorhinootologie. 2014 Mar;93 Suppl 1: S84-102.

Glositis. Gingivitis

Halitosis

  • Cabrera A, Brea M. A propósito de un caso de halitosis. FMC. 2006;13:19-20.
  • Castiñeira C, Boyero L, Rodriguez C, Ollarves J. Halitosis. 2017. [consulta realizada el 10 Sep 2018]. Disponible en: http://www.fisterra.com/fisterrae/guias
  • Martínez A. Halitosis. AMF 2007:3(6):334-7.
  • Monfort Codinach M., Jané Salas E.. Halitosis: diagnóstico y tratamiento. Av Odontoestomatol [Internet]. 2014 Jun [citado 2018 Sep 29] ; 30( 3 ): 155-160. Disponible en: http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0213-12852014000300009&lng=es
  • Pedrazzi V, Nascimento C, Mardegan Issa JP, Fedorowicz Z. Intervenciones para el manejo de la halitosis. Base de Datos Cochrane de Revisiones Sistemáticas 2016, Número 5. Arte. No .: CD012213.
  • Porter S, Scully C. Oral malodour (halitosis). BMJ 2006;333:632-5.
  • Seemann R1, Conceicao MD, Filippi A, Greenman J, Lenton P, Nachnani S, Quirynen M, Roldan S, Schulze H, Sterer N, Tangerman A, Winkel EG, Yaegaki K, Rosenberg M. Halitosis management by the general dental practitioner--results of an international consensus workshop. J Breath Res. 2014 Mar;8(1):017101.

Laringitis aguda. Laringitis crónica. Crup

  • Alberta Clinical Practice Guidelines/Toward Optimized Practice (TOP). Guideline on diagnosis and management of croup. TOP 2008 Jan. http://topalbertadoctors.org/download/252/croup_guideline.pdf?_20180930180953
  • Bjornson CL, Johnson DW. Croup. Lancet 2008;371:329-39.
  • Callén M, Cortés O. El Pediatra de Atención Primaria y la Laringitis Aguda – Crup. Protocolos del GVR (publicación P-GVR-5). 2010 [consulta realizada el 20 Feb 2012]. Disponible en: www.aepap.org/gvr/protocolos.htm
  • Cherry JD. Croup. N Engl J Med 2008;358:384-91.
  • Clinical Evidence. Croup. [consulta realizada el 3 Jul 2008]. Disponible en: www.clinicalevidence.com
  • DynaMed Plus [Internet]. Ipswich (MA): Servicios de información EBSCO. 1995 -. Registro No. 115115, Laringitis; [actualizado 2018 ago, Consulta realizada el 30 Sep 2018]; Disponible en: http://www.dynamed.com/login.aspx?direct=true&site=DynaMed&id=115115
  • Petrocheilou A1, Tanou K, Kalampouka E, Malakasioti G, Giannios C, Kaditis AG. Viral croup: diagnosis and a treatment algorithm. Pediatr Pulmonol. 2014 May;49(5):421-9.
  • Reveiz L, Cardona AF. Antibióticos para la laringitis aguda en adultos. Cochrane Database Syst Rev 2013 ; 3 : CD004783.
  • Russell KF, Liang Y, O'Gorman K, Johnson DW, Klassen TP. Glucocorticoids for croup.
    Cochrane Database Syst Rev. 2011 Jan 19;(1):CD001955.
  • Smith D, McDermott A, Sullivan J.Croup: Diagnosis and Management. Am Fam Physician. 2018 May 1;97(9):575-580.
  • Wood J, Athanasiadis T, Allen J. Laryngitis. BMJ 2014; 349: g5827

Litiasis salivar

  • Guerra A, Katz P. Litotricia extracorpórea por ondas de choque (LEOC) de las piedras de glándulas salivales: Estudio retrospectivo de 1.571 pacientes. Rev Maxilofac Stomatol Chir. 2011 Apr;112(2):75-9.
  • Iro H, Zenk J, Escudier MP, Nahlieli O, Capaccio P, Katz P, et al. Outcome of minimally invasive management of salivary calculi in 4,691 patients. Laryngoscope. 2009;119(2):263.
  • Koch M, Zenk J, Iro H. Algoritmos para el tratamiento de las obstrucciones glándula salival. Otolaryngol Clin North Am. 2009 Dec;42(6):1173-92.
  • Roccia P, Di Liberto C, Speciale R, La Torretta G, Lo Muzio L, Campisi G. Sialoadenitis obstructiva: actualización de las cuestiones de diagnóstico y terapia. Recenti Prog Med. 2006 May;97(5):272-9.

Otitis externa aguda

  • Costa C, Amor JC. Otitis externa. Fisterra 2017. Disponible en : http://www.fisterra.com/fisterrae
  • Pistorius, B, Westburry, K, Drehobl, M. Prospective, randomized, comparative trial of ciprofloxacin otic drops, with or without hydrocortisone, vs. polymyxin B-neomycin-hydrocortisone otic suspension in the treatment of acute diffuse otitis externa. Infect Dis Clin Pract. 1999;8:387-395. Disponible en: https://insights.ovid.com/crossref?an=00019048-199911000-00009
  • Roberts DB. La etiología de la miringitis bullosa y el papel de los micoplasmas en enfermedades del oído: una revisión. Pediatrics. 1980 Apr;65(4):761-6.
  • Rosenfeld RM, Schwartz SR, Cannon CR, et al; American Academy of Otolaryngology-Head and Neck Surgery Foundation. Clinical practice guideline: acute otitis externa. Otolaryngol Head Neck Surg. 2014 Feb;150(1 Suppl):S1-S24. http://journals.sagepub.com/doi/full/10.1177/0194599813517083
  • Sander R. Otitis externa: una guía práctica para el tratamiento y la prevención. Fam Physician Soy. 2001 Mar 1;63(5):927-36, 941-2.
  • Vivek Kaushik, Tass Malik, Shakeel R Saeed. Intervenciones para la otitis externa aguda (Revision Cochrane traducida). En: Biblioteca Cochrane Plus 2010, Número 1. Oxford: Update Software Ltd. Disponible en: https://www.cochrane.org/es/CD004740 (Traducida de The Cochrane Library, 2010 Issue 1 Art no. CD004740. Chichester, UK: John Wiley & Sons, Ltd.).
  • Otitis
  • Vennewald I , E Klemm . Otomycosis: Diagnosis and treatment. Dermatol Clin. 2010;28(2):202-11.

Otitis media crónica simple

  • Macfadyen CA, Acuin JM, Gamble C. Antibióticos tópicos sin esteroides para la secreción ótica crónica con perforación de tímpano subyacente (Revisión Cochrane traducida). En: La Biblioteca Cochrane Plus, 2008, Número 4. Oxford: Update Software Ltd. Disponible en: http://www.update-software.com
  • WHO. Chronic suppurative otitis media. Burden of illness and management options. 2004.

Otitis media serosa

  • Griffin G, Flynn CA. Antihistamines and/or decongestants for otitis media with effusion (OME) in children. Cochrane Database of Systematic Reviews, September 2011.
  • Perera R, Glasziou PP, Heneghan CJ, McLellan J, Williamson I. Autoinflation for hearing loss associated with otitis media with effusion. Cochrane Database of Systematic Reviews 2013, Issue 5. Art. No.: CD006285. DOI: 10.1002/14651858.CD006285.pub2.

  • Principi N, Marchisio P, Esposito S. Otitis media with effusion: benefits and harms of strategies in use for treatment and prevention. Expert Rev Anti Infect Ther. 2016;14(4):415-23. doi: 10.1586/14787210.2016.1150781. Epub 2016 Feb 26.
  • Simpson SA, Lewis R, van der Voort J, Butler CC. Oral or topical nasal steroids for hearing loss associated with otitis media with effusion in children. Cochrane Database of Systematic Reviews 2011, Issue 5. Art. No.: CD001935. DOI: 10.1002/14651858.CD001935.pub3.
  • Steel D, Adam GP, Di M, Halladay C, Pan I, Coppersmith N, Balk EM, Trikalinos TA. ympanostomy Tubes in Children With Otitis Media. Comparative Effectiveness Review No. 185. (Prepared by the Brown Evidence-based Practice Center under Contract No. 290-2015-00002-I.) AHRQ Publication No. 17-EHC003-EF. Rockville, MD: Agency for Healthcare Research and Quality; May 2017. www.effectivehealthcare.ahrq.gov/reports/final.cfm. doi: https://doi.org/10.23970/AHRQEPCCER185Link to Exit Disclaimer.
  • Rosenfeld R, Shin J, Schwartz S. Clinical Practice Guideline: Otitis Media with Effusion (Update). Otolaryngology–Head and Neck Surgery. Vol 154, Issue 1_suppl, pp. S1 - S41 First Published February 1, 2016 https://doi.org/10.1177/0194599815623467
  • Venekamp RP, Burton MJ, van Dongen TMA, van der Heijden GJ, van Zon A, Schilder AGM. Antibiotics for otitis media with effusion in children. Cochrane Database of Systematic Reviews 2016, Issue 6. Art. No.: CD009163. DOI: 10.1002/14651858.CD009163.pub3.

  • Venekamp RP, Mick P, Schilder AG, Nunez DA. Grommets (ventilation tubes) for recurrent acute otitis media in children. Cochrane Database Syst Rev. 2018 May 9;5:CD012017. doi: 10.1002/14651858.CD012017.pub2.

Otitis media aguda simple o supurada

Pérdida traumática de un diente

  • Day P, Duggal M. Intervenciones para el tratamiento de los dientes frontales permanentes traumatizados: avulsionados (expulsados) y recolocados (Revision Cochrane traducida). En: Biblioteca Cochrane Plus 2010 Número 1. Oxford: Update Software Ltd. Disponible en: http://www.update-software.com.
  • Flores MT, Andersson L, Andreasen JO, Bakland LK, Malmgren B, Barnett F, et al. Guidelines for the management of traumatic dental injuries. Dental Tratumatology. 2007;23:66-71.
  • Rodríguez M, Naya C, Blanco E. Traumatismos dentales. 2001. Fisterrae 2011. Disponible en: http://www.fisterra.com/fisterrae/
  • Scottish Dental. Clinical Effectiveness Programme. Management of Acute Dental Problems. Guidance for healthcare professionals. Disponible en http://www.sdcep.org.uk/wp-content/uploads/2013/03/SDCEP+MADP+Guidance+March+2013.pdf

Poliposis nasal

Queilitis angular

  • García E, Blanco A, Rodríguez L, Reyes D, Sotres J. Queilitis. Revisión bibliográfica. Rev Cubana Estomatol. 2003;40(3).
  • Johnson VB, Chalmers J. Oral hygiene care for functionally dependent and cognitively impaired older adults. Iowa City (IA): University of Iowa College of Nursing, John A. Hartford Foundation Center of Geriatric Nursing Excellence; 2011 Jul. 61 p.

Resfriado común

  • Deckx L , De Sutter AIM , Guo L , Mir NA , van Driel ML . Descongestionantes nasales en monoterapia para el resfriado común . Base de datos Cochrane de revisiones sistemáticas 2016 , edición 10 . Art. No .: CD009612. DOI: 10.1002 / 14651858.CD009612.pub2. . Consulta realizada el 10 Sep 2018] Disponible en: http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD009612.pub2/full
  • Harris AM, Hicks LA, Qaseem A, for the High Value Care Task Force of the American College of Physicians and for the Centers for Disease Control and Prevention.Appropriate antibiotic use for acute respiratory tract infection in adults: Advice for high-value care from the American College of Physicians and the Centers for Disease Control and Prevention.Ann Intern Med. 2016;164:425–34.
  • Hemilä H , Chalker E . Vitamina C para prevenir y tratar el resfriado común . Base de datos Cochrane de revisiones sistemáticas 2013 , edición 1 . Art. No .: CD000980. DOI: 10.1002 / 14651858.CD000980.pub4. Consulta realizada el 10 Sep 2018]. Disponible en: http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD000980.pub4/full
  • Little P, Stuart B, Mullee M, Thomas T, Johnson S, Leydon G, et al; for the SNIFS Study Team. Effectiveness of steam inhalation and nasal irrigation for chronic or recurrent sinus symptoms in primary care: a pragmatic randomized controlled trial. CMAJ. 2016;188:940–9.
  • Sexton D, McClain M. the common cold in adults treatment and prevention. Post TW, ed. UpToDate. Waltham, MA: UpToDate Inc. (Allan, G. Michael, and Bruce Arroll. “Prevention and Treatment of the Common Cold: Making Sense of the Evidence.” CMAJ : Canadian Medical Association Journal 186.3 (2014): 190–199. PMC. Web. 8 Oct. 2018.Acceso 11 Nov 2017). Disponible en: http://www.uptodate.com

Rinitis alérgica

  • Bousquet J, Anto JM, Bachert C, Baiardini I, Bosnic-Anticevich S, Walter Canonica G, Melén E, Palomares O, Scadding GK, Togias A, Toppila-Salmi S. Allergic rhinitis. Nat Rev Dis Primers. 2020 Dec 3;6(1):95. doi: 10.1038/s41572-020-00227-0. PMID: 33273461.

  • Bousquet, J. et al. 2019 ARIA care pathways for allergen immunotherapy. Allergy 74, 2087-2102 (2019).

  • Fokkens WJ, Lund VJ, Mullol J. European Position Paper on Nasal Polyps Rhinology. 2007; 45(suppl 20):1-139.
  • Jacob E. Pólipos nasales 2008. Fisterrae. Disponible en :www.fisterra.com/fisterrae
  • Martín A, Romero E, De Mier M. La obstrucción nasal crónica. FMC. 2006:13:112-21.
  • Nurmatov U, Dhami S, Arasi S, Roberts G, Pfaar O, Muraro A, et al. Allergen immunotherapy for allergic rhinoconjunctivitis: a systematic overview of systematic reviews. Clin Transl Allergy. 2017 Aug 8;7:24. doi: 10.1186/s13601-017-0159-6. PMID: 28794855; PMCID: PMC5547534.

  • Romero E, Martín A, De Mier M, Maqueda T, Lahoz B. Guía de rinitis 2006. [Consultada el 11 jul 2008]. Disponible en: http://www.fisterra.com/fisterrae/
  • Scadding GK, Durham SR, Mirakian R, Jones NS, Drake-Lee AB, Ryan D, et al. BSACI guidelines for the management of rhinosinusitis and nasal polyposis. Clin Exp Allergy. 2008;38(2):260-75.
  • Sheikh A, Hurwitz B, Nurmatov U, van Schayck CP. House dust mite avoidance measures for perennial allergic rhinitis. Cochrane Database of Systematic Reviews 2010, Issue 7. Art. No.: CD001563. DOI: 10.1002/14651858.CD001563.pub3.
  • Schuler Iv CF, Montejo JM. Allergic Rhinitis in Children and Adolescents. Pediatr Clin North Am. 2019 Oct;66(5):981-993. doi: 10.1016/j.pcl.2019.06.004. Epub 2019 Aug 5. PMID: 31466686.

Rinitis farmacológica

  • DynaMed Plus [Internet]. Ipswich (MA): EBSCO Information Services. 1995 - . Record No. 116234, Rhinitis medicamentosa; [updated 2018 Jan 04]. Disponible en: http://www.dynamed.com/login.aspx?direct=true&site=DynaMed&id=116234. Registration and login required.
  • Wallace DV, Dykewicz MS, Bernstein DI, Blessing-Moore J, Cox L, Khan DA, et al, Joint Task Force on Practice, American Academy of Allergy, Asthma & Immunology, American College of Allergy, Asthma and Immunology, Joint Council of Allergy, Asthma and Immunology. The diagnosis and management of rhinitis: an updated practice parameter. J Allergy Clin Immunol. 2008 Aug;122(2 Suppl):S1-84.

Rinitis vasomotora

  • 2007 Annual evidence update on rhinitis: non-allergic rhinitis. Disponible en: http://www.library.nhs.uk/ent/ViewResource.aspx?resID=260110
  • Banov CH, Lieberman P; Vasomotor Rhinitis Study Groups. Efficacy of azelastine nasal spray in the treatment of vasomotor (perennial nonallergic) rhinitis. Ann Allergy Asthma Immunol. 2001 Jan;86(1):28-35.
  • Ciprandi G. Treatment of nonallergic perennial rhinitis. Allergy. 2004;59(Suppl 76):16-22.
  • DynaMed Plus [Internet]. Ipswich (MA): EBSCO Information Services. 1995 - . Record No. 114903, Vasomotor rhinitis; [updated 2015 Aug 07]; Disponible en: http://www.dynamed.com/login.aspx?direct=true&site=DynaMed&id=114903. Registration and login required.
  • Gehanno P, Deschamps E, Garay E, Baehre M, Garay RP. Vasomotor rhinitis: clinical efficacy of azelastine nasal spray in comparison with placebo. ORL J Otorhinolaryngol Relat Spec. 2001 Mar-Apr;63(2):76-81.
  • Pattanaik D,Lieberman P. Vasomotor Rhinitis. Curr Allergy Asthma Rep. 2010;10(2):84-91, 215.
  • Scadding GK, Durham SR, Mirakian R, et al. BSACI guidelines for the management of allergic and non-allergic rhinitis. Clinical and Experimental Allergy. 2008;38(1):19-42.

Sinusitis aguda

  • Ahovuo-Saloranta A, Rautakorpi UM, Borisenko OV, et al. Antibióticos para la sinusitis maxilar aguda en adultos. Base de datos Cochrane Syst Rev 2014; : CD000243.
  • Castiñeiras C, Jacob E, Amor J. Rinosinusitis aguda 2014. Fisterra. [acceso 11 Nov 2017]. Disponible en: www.fisterra.com/fisterrae
  • Cordero E, Alcántara J, Caballero J, De la Torre J, Girón J, Lama C. Aproximación clínica y terapéutica a las infecciones de las vías respiratorias. Documento de consenso de la Sociedad Andaluza de enfermedades infecciosas y de la Sociedad Andaluza de Medicina de Familia y Comunitaria. Enfermedades infecciosas, microbiología clínica. Barcelona 2007;25(4):253-62.
  • DynaMed Plus [Internet]. Ipswich (MA): Servicios de información EBSCO. 1995 - .Registro No. 113862, Acute rhinosinusitis in children. Update 2017 Sep 07. Disponible en: http://www.dynamed.com/topics/dmp~AN~T902949/Acute-sinusitis-in-children-and-adolescents
  • Kim Ah-See. Sinusitis aguda. En: Centro Cochrane Iberoamericano. Evidencia Clínica. 2 ed. Bogotá: Legis; 2006-07. p. 486-8.
  • Lemiengre MB, van Driel ML, Merenstein D, Liira H, Mäkelä M, De Sutter AIM. Antibiotics for acute rhinosinusitis in adults. Cochrane Database of Systematic Reviews 2018, Issue 9. Art. No.: CD006089. DOI: 10.1002/14651858.CD006089.pub5. Disponible en: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006089.pub5/full/es
  • Llor C, Moragas A, Bayona C. Infecciones del trato respiratorio superior. AMF. 2015;11(3):124-31.
  • Llor C. Los principales problemas de salud sobre Infecciones del tracto respiratorio: el año de las pautas cortas (AMF 2018) Actualizaciones de los principales problemas de salud. AMF 2018;14(6):2244.
  • Martínez Campos L., Albañil Ballesteros R., Flor Bru J. de la, Piñeiro Pérez R., Cervera J., Baquero Artigao F. et al . Documento de consenso sobre etiología, diagnóstico y tratamiento de la sinusitis. Rev Pediatr Aten Primaria [Internet]. 2013 Sep [citado 2019 Oct 07]; 15( 59 ): 203-218. Disponible en: http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1139-76322013000400002&lng=es. http://dx.doi.org/10.4321/S1139-76322013000400002.
  • Muguruza A, Cámara A, Arranz L, Abrego M. Rinosinusitis aguda. OSI Donostialdea. Guía de tratamiento de las enfermedades infecciosas en atención primaria (Pediatría). 2017. P 48-49.
  • Orlandi R, Kingdom T, Hwang P, Smith T. International Consensus Statement on Allergy and Rhinology: Rhinosinusitis. Int Forum Allergy Rhinol. 2016 Feb;6 Suppl 1:S22-209. doi: 10.1002/alr.21695.
  • Venekamp RP, Thompson MJ, Hayward G, et al. Corticosteroides sistémicos para la sinusitis aguda. Base de datos Cochrane Syst Rev 2014; : CD008115.
  • Williamson IG, Rumsby K, Benge S, Moore M, Smith PW, Cross M, Little P. Antibiotics and topical nasal steroid for treatment of acute maxillary sinusitis. A randomized controlled trial. JAMA. 2007;298:2487-96.
  • Wilson J. Acute Sinusitis. Ann Intern Med. 2010;153:ITC3-1.
  • Zalmanovici Trestioreanu A, Yaphe J. Esteroides intranasales para la sinusitis aguda. Base de datos Cochrane Syst Rev 2013; : CD005149.

Sinusitis crónica

  • Ah-See KL, MacKenzie J, Ah-See KW. Management of chronic rhinosinusitis. BMJ. 2012 Oct 30;345:e7054.
  • Fokkens WJ, Lund VJ, Mullol J, et al. European Position Paper on Rhinosinusitis and Nasal Polyps 2012. Rhinol Suppl. 2012 Mar;(23):1-298 PDF.
  • Joe S A, Thambi R, Huang J. A systematic review of the use of intranasal steroids in the treatment of chronic rhinosinusitis. Otolaryngology - Head and Neck Surgery. 2008;139(3):340-7.
  • Piromchai P, Thanaviratananich S, Laopaiboon M. Systemic antibiotics for chronic rhinosinusitis without nasal polyps in adults. Cochrane Database of Systematic Reviews 2011, Issue 5. Art. No.: CD008233. DOI: 10.1002/14651858.CD008233.pub2.
  • Rosenfeld RM, Piccirillo JF, Chandrasekhar SS, et al. Clinical practice guideline (update): adult sinusitis. Otolaryngol Head Neck Surg. 2015 Apr;152(2 Suppl):S1-S39.
  • Scadding GK, Durham SR, Mirakian R, Jones NS, Drake-Lee AB, Ryan D, et al. BSACI guidelines for the management of rhinosinusitis and nasal polyposis. Clin Exp Allergy 2008;38(2):260-75.
  • Snidvongs K, Kalish L, Sacks R, Craig JC, Harvey RJ. Topical steroid for chronic rhinosinusitis without polyps. Cochrane Database of Systematic Reviews 2011, Issue 8. Art. No.: CD009274. DOI: 10.1002/14651858.CD009274.

Sordera

Sordera súbita idiopática

  • Awad Z, Huins C, Pothier DD. Antivirals for idiopathic sudden sensorineural hearing loss. Cochrane Database Syst Rev. 2012; CD006987
  • Cosentino ML, Schulman A, Bercellini E, Spandonari R, Laurnagaray V, Soricelli E, et al. Tasa de recuperación en hipoacusia súbita: experiència 2011-2012. FASO. [Internet]. 2014; 21(3): 27-32. Disponible en: http://www.faso.org.ar/revistas/2014/3/4.pdf
  • Crane RA, Camilon M, Nguyen S, Meyer TA. Steroids for treatment of sudden sensorineural hearing loss: a meta-analysis of randomized controlled trials. Laringoscope 2015; 125(1): 209-17.
  • Maggie K, Selena E. Sudden sensorineural Hearinh Loss. A review of Daignosis, Treatment, and Prognosis. Trends Amplif. 2011; 15(3): 91-105.
  • Peter C Weber. Sudden sensorineural hearing loss. Literature review current through 2017. Uptodate 2017. Disponible en: http://www.uptodate.com
  • Plaza G, Durio E, Herráiz C, Rivera T, García-Berrocal J. Consenso sobre el diagnóstico y tratamiento de la sordera súbita. Acta Otorrinolaringol Esp. 2011; 62: 144-57. DOI: 10.1016/j.otorri.2010.09.001
  • Schreiber B. Sudden sensorineural hearing loss. Lancet. 2010; 375 (9721): 1203-11.
  • Stachler R, Chandrasekhar S, Archer S. Clinical practice guideline: sudden hearing loss. Otolaryngol Head Neck Surg. 2012;146(3 Suppl):S1-35.
  • Wei BP, Stathopoulos D, O'Leary S. Steroids for idiopathic sudden sensorineural hearing loss. Cochrane Database Syst Rev. 2013: CD003998.

Tapón de cera

Xerostomía

  • Davies AN, Thompson J. Parasympathomimetic drugs for the treatment of salivary gland dysfunction due to radiotherapy. Cochrane Database of Systematic Reviews 2015, Issue 10. Art. No.: CD003782. DOI: 10.1002/14651858.CD003782.pub3. Accessed 12 October 2021. Disponible en: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003782.pub3/full
  • Ramos-Casals M, Brito-Zerón P, Bombardieri S On behalf of the EULAR-Sjögren Syndrome Task Force Group, et al EULAR recommendations for the management of Sjögren’s syndrome with topical and systemic therapies Annals of the Rheumatic Diseases 2020;79:3-18.
  • Salum FG, Medella-Junior FAC, Figueiredo MAZ, Cherubini K. Salivary hypofunction: An update on therapeutic strategies. Gerodontology 2018; 35:305.
  • Plemons JM, Al-Hashimi I, Marek CL, American Dental Association Council on Scientific Affairs. Managing xerostomia and salivary gland hypofunction: executive summary of a report from the American Dental Association Council on Scientific Affairs. J Am Dent Assoc 2014; 145:867.